JP2021533128A5 - - Google Patents
Info
- Publication number
- JP2021533128A5 JP2021533128A5 JP2021505721A JP2021505721A JP2021533128A5 JP 2021533128 A5 JP2021533128 A5 JP 2021533128A5 JP 2021505721 A JP2021505721 A JP 2021505721A JP 2021505721 A JP2021505721 A JP 2021505721A JP 2021533128 A5 JP2021533128 A5 JP 2021533128A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- pharmaceutical composition
- spa
- composition according
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862713061P | 2018-08-01 | 2018-08-01 | |
| US62/713,061 | 2018-08-01 | ||
| PCT/US2019/044023 WO2020028290A1 (en) | 2018-08-01 | 2019-07-30 | Methods for treating neurodegenerative disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021533128A JP2021533128A (ja) | 2021-12-02 |
| JP2021533128A5 true JP2021533128A5 (cg-RX-API-DMAC7.html) | 2022-08-04 |
| JP7573512B2 JP7573512B2 (ja) | 2024-10-25 |
Family
ID=67614642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021505721A Active JP7573512B2 (ja) | 2018-08-01 | 2019-07-30 | 神経変性障害を治療するための方法 |
Country Status (27)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2021001287A (es) * | 2018-08-01 | 2021-07-15 | Alzheon Inc | Métodos para tratar trastornos neurodegenerativos. |
| PH12021553196A1 (en) * | 2019-06-17 | 2022-11-07 | Alzheon Inc | Methods for treating neurodegenerative disorders |
| AU2022405026A1 (en) * | 2021-12-09 | 2024-06-20 | Alzheon, Inc. | Alz-801 for use in treating alzheimer's disease |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5840294A (en) * | 1993-03-29 | 1998-11-24 | Queen's University At Kingston | Method for treating amyloidosis |
| SI2089417T1 (sl) * | 2006-10-12 | 2015-04-30 | Bhi Limited Partnership | Metode, spojine, sestavki in vektorji za dostavo 3-amino-1-propansulfonske kisline |
| EP2852388A4 (en) | 2012-05-23 | 2016-01-13 | Univ Johns Hopkins | COMPOUNDS AND METHOD FOR USE THEREOF FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES |
| WO2014121083A1 (en) * | 2013-01-31 | 2014-08-07 | President And Fellows Of Harvard College | Methods of increasing neuronal connectivity and/or treating a neurodegenerative condition |
| ES2960625T3 (es) * | 2014-03-21 | 2024-03-05 | Alzheon Inc | Compuestos para uso en el tratamiento de la enfermedad de Alzheimer en pacientes de ApoE4+/+ |
| EP3347002B1 (en) * | 2015-09-10 | 2023-06-07 | Alzheon, Inc. | Treatment of alzheimer's disease in a particular patient population |
| MX2021001287A (es) * | 2018-08-01 | 2021-07-15 | Alzheon Inc | Métodos para tratar trastornos neurodegenerativos. |
-
2019
- 2019-07-30 MX MX2021001287A patent/MX2021001287A/es unknown
- 2019-07-30 BR BR112021001739-9A patent/BR112021001739A2/pt unknown
- 2019-07-30 US US17/264,477 patent/US12083082B2/en active Active
- 2019-07-30 EA EA202190406A patent/EA202190406A1/ru unknown
- 2019-07-30 AU AU2019315853A patent/AU2019315853B2/en active Active
- 2019-07-30 SI SI201930898T patent/SI3829563T1/sl unknown
- 2019-07-30 PL PL19752795.5T patent/PL3829563T3/pl unknown
- 2019-07-30 ES ES19752795T patent/ES3011716T3/es active Active
- 2019-07-30 MY MYPI2021000515A patent/MY206530A/en unknown
- 2019-07-30 SG SG11202100767XA patent/SG11202100767XA/en unknown
- 2019-07-30 IL IL280424A patent/IL280424B2/en unknown
- 2019-07-30 HR HRP20250206TT patent/HRP20250206T1/hr unknown
- 2019-07-30 HU HUE19752795A patent/HUE070101T2/hu unknown
- 2019-07-30 DK DK19752795.5T patent/DK3829563T3/da active
- 2019-07-30 LT LTEPPCT/US2019/044023T patent/LT3829563T/lt unknown
- 2019-07-30 KR KR1020217005803A patent/KR102716959B1/ko active Active
- 2019-07-30 EP EP19752795.5A patent/EP3829563B1/en active Active
- 2019-07-30 RS RS20250164A patent/RS66516B1/sr unknown
- 2019-07-30 WO PCT/US2019/044023 patent/WO2020028290A1/en not_active Ceased
- 2019-07-30 CN CN201980064415.6A patent/CN112867485A/zh active Pending
- 2019-07-30 FI FIEP19752795.5T patent/FI3829563T3/fi active
- 2019-07-30 JP JP2021505721A patent/JP7573512B2/ja active Active
- 2019-07-30 PT PT197527955T patent/PT3829563T/pt unknown
- 2019-07-30 UA UAA202101015A patent/UA130011C2/uk unknown
- 2019-07-30 SM SM20250080T patent/SMT202500080T1/it unknown
-
2021
- 2021-01-28 PH PH12021550213A patent/PH12021550213A1/en unknown
- 2021-02-01 CL CL2021000269A patent/CL2021000269A1/es unknown
-
2024
- 2024-08-02 US US18/793,452 patent/US20250213507A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7862354B2 (ja) | 補体活性のモジュレーター | |
| Cascino et al. | Plasma and cerebrospinal fluid amino acid patterns in hepatic encephalopathy | |
| JP2009542611A (ja) | アルファ−シヌクレイン凝集の阻害 | |
| US20200392181A1 (en) | Peptide compositions and related methods | |
| FI3746467T3 (fi) | Muutetut lipidoidut relaksiinin b-ketjun peptidit ja niiden terapeuttinen käyttö | |
| JP2004521123A5 (cg-RX-API-DMAC7.html) | ||
| JP2021527670A5 (cg-RX-API-DMAC7.html) | ||
| WO2018048944A1 (en) | Methods of treating iron overload | |
| TWI866551B (zh) | 穩定抗體組合物 | |
| TW200410681A (en) | Amino acid compound for improving central function | |
| JP7573512B2 (ja) | 神経変性障害を治療するための方法 | |
| AU2017319512A2 (en) | Use of CGRP receptor antagonists in neuroprotection and neurological disorders | |
| JP7784378B2 (ja) | タウオパチーを処置するためのペプチド組成物及び方法 | |
| CN115279341A (zh) | 胰高血糖素类似物的液体制剂 | |
| TH2101000540A (th) | องค์ประกอบทางเภสัชกรรมที่ประกอบรวมด้วยกรดซัลโฟโพรพาโนอิกสำหรับการผลิตยาสำหรับการรักษาความผิดปกติที่เกิดจากความเสื่อมของระบบประสาท | |
| JP7464310B2 (ja) | Wntシグナル伝達経路の抑制剤 | |
| WO2013137606A1 (ko) | 동맥경화 예방 또는 치료용 약제학적 조성물 | |
| JP2001172190A (ja) | 乳酸蓄積抑制剤 | |
| HK40119431A (en) | Stable antibody composition | |
| CN118984715A (zh) | 包含新型肽的用于治疗黄斑变性的组合物 | |
| CN115974973A (zh) | 一种抑制trpm8的多肽及其用途 | |
| CN116802208A (zh) | 帕金森氏病的治疗 | |
| US20210171604A1 (en) | Peptides for the treatment of type 2 diabetes | |
| HK40031446B (en) | Modulators of complement activity | |
| BR112018012174B1 (pt) | Composição farmacêutica que compreende um polipeptídeo inibidor de c5, kit, dispositivo de auto injetor e uso |